Hannes H.
Director/Board Member at Peptilogics, Inc.
Profile
Mr. Hannes H. is a Director, Life Science Investments & Data Science at Thiel Capital LLC.
He is on the Board of Directors at Peptilogics, Inc. Mr. H.
was previously employed as a Board of Directors by Blackrock Microsystems, Inc., a Board of Directors by Beijing Imunopharm Technology Co., Ltd., and a Senior Advisor by GWC, Inc. He received his undergraduate degree from the University of California San Diego.
Hannes H. active positions
Companies | Position | Start |
---|---|---|
Thiel Capital LLC
Thiel Capital LLC Investment ManagersFinance Thiel Capital LLC (Thiel Capital) is a venture capital firm founded in 2011 by Peter Andreas Thiel. The firm is headquartered in West Hollywood, California. | Private Equity Investor | 2017-12-31 |
Peptilogics, Inc.
Peptilogics, Inc. Miscellaneous Commercial ServicesCommercial Services Peptilogics, Inc. operates as an early-stage biotechnology company, that develops a new class of antibiotics with a novel mechanism of action derived from their eCAP (engineered cationic antibiotic peptide) platform for the treatment of multidrug-resistant infections. Its platform has the potential to produce antibiotics with broad-spectrum activity with low risk of generating resistance, due to the unique mechanism of action involving the targeted disruption of bacterial membranes. The company was founded by Jonathan Steckbeck and is headquartered in Pittsburgh, PA. | Director/Board Member | 2017-12-31 |
Former positions of Hannes H.
Companies | Position | End |
---|---|---|
Beijing Imunopharm Technology Co., Ltd.
Beijing Imunopharm Technology Co., Ltd. BiotechnologyHealth Technology Beijing Immunochina Pharmaceuticals Co., Ltd. engages in the development of CAR-T technology and CAR-T cell products. The company was founded on April 14, 2015 by He Ting, Lu Xian, and Qi Fei Fei and is headquartered in Beijing, China. | Director/Board Member | 2021-12-31 |
GWC, Inc.
GWC, Inc. Investment ManagersFinance GWC Inc (GWC) is a venture capital firm founded in 2008 by Wen Chu and Yiqun Bo. The firm is headquartered in Santa Clara, California. | Consultant / Advisor | 2017-12-30 |
Blackrock Microsystems, Inc.
Blackrock Microsystems, Inc. Packaged SoftwareTechnology Services Blackrock Microsystems, Inc. is a platform company that specializes in brain-computer interface (BCI) technology and the development of implantable solutions that improve human lives. The company is based in Salt Lake City, UT and has subsidiaries in the United States. Blackrock's precision electrode technology is at the core of many worldwide innovations in BCI, enabling dozens of early users to regain their ability to see, hear, move, and talk. Blackrock Microsystem's mission is to provide innovative tools and neurotech expertise to translate technology into novel, implantable clinical solutions that improve human lives. The company was founded in 2008 by Marcus Gerhardt and Florian Solzbacher, with Marcus Gerhardt serving as the CEO since then. | Director/Board Member | - |
Training of Hannes H.
University of California San Diego | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 5 |
---|---|
Thiel Capital LLC
Thiel Capital LLC Investment ManagersFinance Thiel Capital LLC (Thiel Capital) is a venture capital firm founded in 2011 by Peter Andreas Thiel. The firm is headquartered in West Hollywood, California. | Finance |
GWC, Inc.
GWC, Inc. Investment ManagersFinance GWC Inc (GWC) is a venture capital firm founded in 2008 by Wen Chu and Yiqun Bo. The firm is headquartered in Santa Clara, California. | Finance |
Beijing Imunopharm Technology Co., Ltd.
Beijing Imunopharm Technology Co., Ltd. BiotechnologyHealth Technology Beijing Immunochina Pharmaceuticals Co., Ltd. engages in the development of CAR-T technology and CAR-T cell products. The company was founded on April 14, 2015 by He Ting, Lu Xian, and Qi Fei Fei and is headquartered in Beijing, China. | Health Technology |
Blackrock Microsystems, Inc.
Blackrock Microsystems, Inc. Packaged SoftwareTechnology Services Blackrock Microsystems, Inc. is a platform company that specializes in brain-computer interface (BCI) technology and the development of implantable solutions that improve human lives. The company is based in Salt Lake City, UT and has subsidiaries in the United States. Blackrock's precision electrode technology is at the core of many worldwide innovations in BCI, enabling dozens of early users to regain their ability to see, hear, move, and talk. Blackrock Microsystem's mission is to provide innovative tools and neurotech expertise to translate technology into novel, implantable clinical solutions that improve human lives. The company was founded in 2008 by Marcus Gerhardt and Florian Solzbacher, with Marcus Gerhardt serving as the CEO since then. | Technology Services |
Peptilogics, Inc.
Peptilogics, Inc. Miscellaneous Commercial ServicesCommercial Services Peptilogics, Inc. operates as an early-stage biotechnology company, that develops a new class of antibiotics with a novel mechanism of action derived from their eCAP (engineered cationic antibiotic peptide) platform for the treatment of multidrug-resistant infections. Its platform has the potential to produce antibiotics with broad-spectrum activity with low risk of generating resistance, due to the unique mechanism of action involving the targeted disruption of bacterial membranes. The company was founded by Jonathan Steckbeck and is headquartered in Pittsburgh, PA. | Commercial Services |
- Stock Market
- Insiders
- Hannes H.